| 000 | 01723 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513141834.0 | ||
| 264 | 0 | _c19980622 | |
| 008 | 199806s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.42.4.739 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Langevelde, P | |
| 245 | 0 | 0 |
_aAntibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cApr 1998 |
||
| 300 |
_a739-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 | _aBacterial Proteins |
| 650 | 0 | 4 |
_aCarbapenems _xpharmacology |
| 650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
| 650 | 0 | 4 |
_aCeftazidime _xpharmacology |
| 650 | 0 | 4 |
_aCephalosporins _xpharmacology |
| 650 | 0 | 4 |
_aGalactose _xmetabolism |
| 650 | 0 | 4 | _aHexosyltransferases |
| 650 | 0 | 4 |
_aImipenem _xpharmacology |
| 650 | 0 | 4 |
_aLipopolysaccharides _xmetabolism |
| 650 | 0 | 4 |
_aMembranes _xdrug effects |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aMuramoylpentapeptide Carboxypeptidase _xmetabolism |
| 650 | 0 | 4 | _aPenicillin-Binding Proteins |
| 650 | 0 | 4 | _aPeptidyl Transferases |
| 650 | 0 | 4 |
_aSalmonella typhi _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aKwappenberg, K M | |
| 700 | 1 | _aGroeneveld, P H | |
| 700 | 1 | _aMattie, H | |
| 700 | 1 | _avan Dissel, J T | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 42 _gno. 4 _gp. 739-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.42.4.739 _zAvailable from publisher's website |
| 999 |
_c9526872 _d9526872 |
||